BGF
Venture capital
RollingLast verified 7 Nov 2026
UK and Ireland growth capital and early-stage investor providing patient, minority equity funding from late seed to Series B and growth stages.
4 deals in the last 24 months, latest 5 Nov 2026. From its website and its deals in the news.
Key facts
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Other deeptech, Biotech & pharma
- Typical round size
- €28.6M (median of its recent deals, not a ticket)
- Leads rounds
- 25% of recent deals with a known role
- Eligible countries
- United Kingdom, Ireland
- Provider based in
- United Kingdom
- Timing
- Rolling applications
- Focus
- UK and Ireland entrepreneurial businesses; deep tech and life sciences startups; growing SMEs
- Does not invest in
- controlling equity stake
- How to apply
- Application form · Apply on their site
- Source
- https://www.bgf.co.uk/
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| FluoRok · United Kingdom | Series A | Materials & chemistry, Industrial & manufacturing, Cleantech | €26.6M | participant | 5 Nov 2026 |
| T-Therapeutics | Series B | Biotech & pharma, Healthtech | €118.5M | participant | 5 Nov 2026 |
| Cambridge GaN Devices | Series C+ | Semiconductors | €30.5M | participant | 18 Feb 2025 |
| DEScycle | Series A | Materials & chemistry, Cleantech, Circular economy | €12.2M | lead | 18 Nov 2024 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Apply link
https://www.bgf.co.uk/looking-for-funding | Looking for Funding?
https://www.bgf.co.uk/ - Kind
Our investment model is purpose-built for growing companies: we never take a controlling equity stake, we believe in a patient approach to investing
https://www.bgf.co.uk/ - Sectors
funding for deep tech and life sciences startups
https://www.bgf.co.uk/
Status history
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at BGF? Claim this profile to confirm what you invest in.